By Rob Curran Boston Scientific posted stronger-than-anticipated growth in fourth-quarter net income and sales and forecast more of the same in 2024, amid.
Shares of Stryker, Boston Scientific and other medical technology companies jumped Wednesday as healthy demand for medical procedures brightened investors'.
Boston Scientific Co. (NYSE:BSX – Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $61.42, but opened at $64.00. Boston Scientific shares last traded at $63.08, with a volume of 1,773,845 shares changing hands. Analyst Ratings Changes A number of equities research analysts have recently […]
Metis Global Partners LLC lifted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 10.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,290 shares of the medical equipment provider’s stock after acquiring an additional 5,875 shares during the quarter. […]
StockNews.com downgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a buy rating to a hold rating in a research report released on Wednesday morning. Other equities analysts have also issued research reports about the company. Needham & Company LLC cut their price target on Boston Scientific from $65.00 to $60.00 and set a […]